However, HADHA, one of the βAMRGs, has been previously implicated in the upregulation of βAMRGs could potentially enhance prognoses in patients with HCC, thereby offering novel insights and avenues for investigating the mechanistic actions of βAMRGs in fundamental research and detrimental effects observed in HCC [30]. Here, HADHA is linked to hepatocellular carcinoma.